Nasdaq · CIK 0001822359
DCGO DocGo Inc.
Insider trading from SEC Form 4. Last filing Mar 31, 2026. Close $0.34 on Oct 9, 2026, 0% from the 52-week low and -77% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
DCGOOct 9, 2026 · close 0.34
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at DocGo Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Ely D Tendler General Counsel and Secretary sell | $15k 16,850 shares | -6% | +5% from low-84% from high | |
| 53Moderate | Michael J Burdiek director buy | $13k 10,000 shares | +2% | +5% from low-76% from high | |
| 48Moderate | Michael J Burdiek director buy | $21k 15,000 shares | +2% | 0% from low-75% from high | |
| 53Moderate | Lee Bienstock Chief Executive Officer buy | $23k 15,000 shares | +1% | 0% from low-75% from high | |
| 55Moderate | Norman Rosenberg CFO and Treasurer buy | $22k 15,000 shares | +2% | 0% from low-75% from high | |
| 48Moderate | Stephen Sugrue Chief Compliance Officer buy | $14k 10,000 shares | +3% | 0% from low-75% from high | |
| 56Moderate | Stephen K. Klasko M.D. director buy | $22k 15,000 shares | - | 0% from low-75% from high | |
| 36Weak | Etalvina Leite director sell | $72k 16,500 shares | -24% | - | |
| 38Weak | Ely D Tendler General Counsel and Secretary sell | $103k 23,088 shares | -12% | - |
Transactions
The last 51 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -18,811 | $0.57 | $11k | 2,817,470 | Mar 31, 2026 |
| Dec 12, 2025 | Stephen Sugrue Chief Compliance Officer | AGrant or award Common Stock | +321,055 | $0.00 | $0 | 672,570 | Dec 16, 2025 |
| Dec 12, 2025 | Ira Smedra director | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 240,999 | Dec 16, 2025 |
| Dec 12, 2025 | Etalvina Leite director | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 201,411 | Dec 16, 2025 |
| Dec 12, 2025 | Lee Bienstock Chief Executive Officer | AGrant or award Common Stock | +1,113,495 | $0.00 | $0 | 3,050,412 | Dec 16, 2025 |
| Dec 12, 2025 | Michael J Burdiek director | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 791,560 | Dec 16, 2025 |
| Dec 12, 2025 | James M Travers director | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 240,999 | Dec 16, 2025 |
| Dec 12, 2025 | Ely D Tendler General Counsel and Secretary | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 275,645 | Dec 16, 2025 |
| Dec 12, 2025 | Norman Rosenberg CFO and Treasurer | AGrant or award Common Stock | +429,405 | $0.00 | $0 | 1,289,345 | Dec 16, 2025 |
| Dec 15, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -214,131 | $0.91 | $195k | 2,836,281 | Dec 16, 2025 |
| Dec 15, 2025 | Stephen Sugrue Chief Compliance Officer | FTax withholding Common Stock | -35,968 | $0.91 | $33k | 636,602 | Dec 16, 2025 |
| Dec 15, 2025 | Norman Rosenberg CFO and Treasurer | FTax withholding Common Stock | -65,774 | $0.91 | $60k | 1,223,571 | Dec 16, 2025 |
| Dec 15, 2025 | Ely D Tendler General Counsel and Secretary | SOpen-market sale Common Stock | -16,850 | $0.91 | $15k | 258,795 | Dec 16, 2025 |
| Sep 10, 2025 | Stephen K. Klasko M.D. director | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 115,000 | Sep 11, 2025 |
| Jul 2, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -18,597 | $1.52 | $28k | 1,936,917 | Jul 2, 2025 |
| Jul 2, 2025 | Norman Rosenberg CFO and Treasurer | FTax withholding Common Stock | -11,332 | $1.52 | $17k | 859,940 | Jul 2, 2025 |
| Jul 2, 2025 | Stephen Sugrue Chief Compliance Officer | FTax withholding Common Stock | -5,813 | $1.52 | $8,836 | 351,515 | Jul 2, 2025 |
| May 23, 2025 | Michael J Burdiek director | POpen-market purchase Common Stock | +10,000 | $1.33 | $13k | 641,560 | May 23, 2025 |
| May 15, 2025 | Michael J Burdiek director | POpen-market purchase Common Stock | +15,000 | $1.43 | $21k | 631,560 | May 15, 2025 |
| May 13, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -15,565 | $1.44 | $22k | 1,955,514 | May 15, 2025 |
| May 14, 2025 | Lee Bienstock Chief Executive Officer | POpen-market purchase Common Stock | +15,000 | $1.54 | $23k | 1,971,079 | May 14, 2025 |
| May 14, 2025 | Norman Rosenberg CFO and Treasurer | POpen-market purchase Common Stock | +15,000 | $1.47 | $22k | 871,272 | May 14, 2025 |
| May 14, 2025 | Stephen Sugrue Chief Compliance Officer | POpen-market purchase Common Stock | +10,000 | $1.44 | $14k | 357,328 | May 14, 2025 |
| May 14, 2025 | Stephen K. Klasko M.D. director | POpen-market purchase Common Stock | +15,000 | $1.49 | $22k | 15,000 | May 14, 2025 |
| Mar 31, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -18,742 | $2.64 | $49k | 1,974,677 | Apr 2, 2025 |
| Apr 2, 2025 | Norman Rosenberg CFO and Treasurer | FTax withholding Common Stock | -8,004 | $2.68 | $21k | 856,272 | Apr 2, 2025 |
| Apr 2, 2025 | Stephen Sugrue Chief Compliance Officer | FTax withholding Common Stock | -5,614 | $2.68 | $15k | 347,328 | Apr 2, 2025 |
| Apr 2, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -18,598 | $2.68 | $50k | 1,956,079 | Apr 2, 2025 |
| Mar 7, 2025 | Lee Bienstock Chief Executive Officer | AGrant or award Common Stock | +465,116 | $0.00 | $0 | 2,052,779 | Mar 11, 2025 |
| Mar 7, 2025 | Norman Rosenberg CFO and Treasurer | AGrant or award Common Stock | +170,543 | $0.00 | $0 | 879,646 | Mar 11, 2025 |
| Mar 7, 2025 | Stephen Sugrue Chief Compliance Officer | AGrant or award Common Stock | +77,520 | $0.00 | $0 | 360,731 | Mar 11, 2025 |
| Mar 7, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -59,360 | $3.03 | $180k | 1,993,419 | Mar 11, 2025 |
| Mar 7, 2025 | Norman Rosenberg CFO and Treasurer | FTax withholding Common Stock | -15,370 | $3.03 | $47k | 864,276 | Mar 11, 2025 |
| Mar 7, 2025 | Stephen Sugrue Chief Compliance Officer | FTax withholding Common Stock | -7,789 | $3.03 | $24k | 352,942 | Mar 11, 2025 |
| Jan 2, 2025 | Stephen Sugrue Chief Compliance Officer | FTax withholding Common Stock | -4,708 | $4.23 | $20k | 283,211 | Jan 6, 2025 |
| Jan 2, 2025 | Norman Rosenberg CFO and Treasurer | FTax withholding Common Stock | -9,180 | $4.23 | $39k | 709,103 | Jan 6, 2025 |
| Jan 2, 2025 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -18,598 | $4.23 | $79k | 1,587,663 | Jan 6, 2025 |
| Dec 13, 2024 | Etalvina Leite director | AGrant or award Common Stock | +34,965 | $0.00 | $0 | 67,911 | Dec 17, 2024 |
| Dec 17, 2024 | Etalvina Leite director | SOpen-market sale Common Stock | -16,500 | $4.34 | $72k | 51,411 | Dec 17, 2024 |
| Dec 12, 2024 | Ely D Tendler General Counsel and Secretary | AGrant or award Common Stock | +35,800 | $0.00 | $0 | 198,733 | Dec 16, 2024 |
| Dec 13, 2024 | Michael J Burdiek director | AGrant or award Common Stock | +34,965 | $0.00 | $0 | 616,560 | Dec 16, 2024 |
| Dec 12, 2024 | Stephen Sugrue Chief Compliance Officer | AGrant or award Common Stock | +107,399 | $0.00 | $0 | 296,653 | Dec 16, 2024 |
| Dec 12, 2024 | Norman Rosenberg CFO and Treasurer | AGrant or award Common Stock | +346,062 | $0.00 | $0 | 737,496 | Dec 16, 2024 |
| Dec 13, 2024 | Ira Smedra director | AGrant or award Common Stock | +34,965 | $0.00 | $0 | 90,999 | Dec 16, 2024 |
| Dec 13, 2024 | James M Travers director | AGrant or award Common Stock | +34,965 | $0.00 | $0 | 90,999 | Dec 16, 2024 |
| Dec 12, 2024 | Lee Bienstock Chief Executive Officer | AGrant or award Common Stock | +536,993 | $0.00 | $0 | 1,692,497 | Dec 16, 2024 |
| Dec 16, 2024 | Ely D Tendler General Counsel and Secretary | SOpen-market sale Common Stock | -23,088 | $4.44 | $103k | 175,645 | Dec 16, 2024 |
| Dec 13, 2024 | Stephen Sugrue Chief Compliance Officer | FTax withholding Common Stock | -8,734 | $4.19 | $37k | 287,919 | Dec 16, 2024 |
| Dec 13, 2024 | Norman Rosenberg CFO and Treasurer | FTax withholding Common Stock | -19,213 | $4.19 | $81k | 718,283 | Dec 16, 2024 |
| Dec 13, 2024 | Lee Bienstock Chief Executive Officer | FTax withholding Common Stock | -86,236 | $4.19 | $361k | 1,606,261 | Dec 16, 2024 |
| Nov 12, 2024 | Stephen K. Klasko M.D. director | AGrant or award Options to purchase Common Stockderivative | +204,082 | $0.00 | $0 | 204,082 | Nov 14, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Lee BienstockChief Executive Officer
- Michael J Burdiekdirector
- Stephen K. Klasko M.D.director
- Etalvina Leitedirector
- Norman RosenbergCFO and Treasurer
- Ira Smedradirector
- Stephen SugrueChief Compliance Officer
- James M Traversdirector
- Ely D TendlerGeneral Counsel and Secretary
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.